yeah, it’s definitely good news. It was worrying me if they...

yeah, it’s definitely good news. It was worrying me if they continued treatment on the SAD patients outside the trial and there was an adverse event that there would be a reaction from the FDA. Apparently they don’t like adverse events happening outside of the trial environment and can be a bit punitive. Now they are inside a trial I am pretty happy. And they can be counted for the safety and efficacy data.

I'm still hoping for some efficacy data in the next week or two. I remember Rohan saying in one of his presentations that if they had more patients show a response they would push the FDA for a faster timeline. An announcement like that with a good double whammy would definitely bring a smile.

I love the way this company keeps pushing to improve their timelines. I also like this the PYC hot copper threads just quietly. Everyone is very respectful of each others views.